We found that SNRPD2 is overexpressed in most human solid tumors and that silencing it is lethal for cancer cells of many tissue origins including short-term cultured patient-derived melanoma cells, but not for non-malignant cells including cancer-associated fibroblasts. Here, SNRPD2 is linked to cancer.